×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| DIVIS LABORATORIES LTD. | 24010 | 5890 | 23190 | 22.20 | 1,52,880 | 74.0 |
| CIPLA LTD. | 51595.7 | 14381.5 | 49708.8 | 17.79 | 119176 | 23.9 |
| TORRENT PHARMACEUTICALS LTD. | 28420 | 5030 | 28090 | 14.88 | 102907 | 55.3 |
Divi's Laboratories Ltd., with Security Code 532488, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,203.9 | 1,823.3 | 1,689.8 | 1,908.1 | 1,730.0 | 1,868.0 | 1,808.0 | 2,259.0 | 2,063.0 | 2,302.0 |
| Expenses | 1,366.3 | 1,214.1 | 1,280.4 | 1,419.5 | 1,239.0 | 1,394.0 | 1,317.0 | 1,542.0 | 1,442.0 | 1,573.0 |
| Operating Profit | 837.6 | 609.3 | 409.4 | 488.7 | 491.0 | 474.0 | 491.0 | 717.0 | 621.0 | 729.0 |
| OPM % | 38% | 33.41% | 24.23% | 25.61% | 28.38% | 25.37% | 27.16% | 31.74% | 30.1% | 31.67% |
| Other Income | 90.0 | 79.3 | 116.3 | 66.2 | 80.0 | 85.0 | 94.0 | 79.0 | 79.0 | 105.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 1.0 | 0.0 | 2.0 | 0.0 | 1.0 |
| Depreciation | 83.4 | 85.5 | 86.5 | 86.6 | 93.0 | 94.0 | 95.0 | 94.0 | 97.0 | 98.0 |
| Profit before tax | 844.1 | 602.9 | 439.1 | 468.0 | 478.0 | 464.0 | 490.0 | 700.0 | 603.0 | 735.0 |
| Tax % | 18.1% | 19.2% | 29.2% | 31.9% | 27.8% | 26.3% | 26.9% | 24.1% | 28.7% | 29.5% |
| Net Profit | 691.6 | 486.9 | 310.9 | 318.8 | 345.0 | 342.0 | 358.0 | 531.0 | 430.0 | 518.0 |
| EPS in Rs | 26.05 | 18.34 | 11.71 | 12.01 | 12.99 | 12.89 | 13.5 | 19.99 | 16.18 | 19.51 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,854.5 | 1,707.7 | 1,950.8 | 1,778.0 | 1,909.0 | 1,855.0 | 2,303.0 | 2,118.0 | 2,338.0 | 2,319.0 |
| Expenses | 1,233.5 | 1,299.4 | 1,463.2 | 1,274.0 | 1,430.0 | 1,366.0 | 1,572.0 | 1,496.0 | 1,622.0 | 1,576.0 |
| Operating Profit | 621.0 | 408.3 | 487.6 | 504.0 | 479.0 | 489.0 | 731.0 | 622.0 | 716.0 | 743.0 |
| OPM % | 33.5% | 23.9% | 25% | 28.3% | 25.1% | 26.4% | 31.7% | 29.4% | 30.6% | 32% |
| Other Income | 80.1 | 114.3 | 66.2 | 81.0 | 86.0 | 95.0 | 79.0 | 79.0 | 106.0 | 82.0 |
| Interest | 0.2 | 0.1 | 0.2 | 0.0 | 1.0 | 0.0 | 2.0 | 0.0 | 1.0 | 0.0 |
| Depreciation | 85.7 | 86.8 | 87.0 | 93.0 | 95.0 | 95.0 | 95.0 | 97.0 | 99.0 | 99.0 |
| Profit before tax | 615.2 | 435.6 | 466.5 | 492.0 | 469.0 | 489.0 | 713.0 | 604.0 | 722.0 | 726.0 |
| Tax % | 19.8% | 29.6% | 31.2% | 27.6% | 25.8% | 26.8% | 24.5% | 28.8% | 29.4% | 18.9% |
| Net Profit | 493.6 | 306.8 | 321.0 | 356.0 | 348.0 | 358.0 | 538.0 | 430.0 | 510.0 | 589.0 |
| EPS in Rs | 18 | 11 | 12 | 13 | 13 | 13 | 20 | 16 | 19 | 22 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 52% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 11% |
| 1 Year: | 58% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 3% |
| 3 Years: | -7% |
| TTM: | 49% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 11% |
| 1 Year: | 58% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|